Expression of tenascin-c and CD44 receptors in cardiac myxomas

Cardiovascular Pathology

Volumn 18, Issue 3, 2009, Pages 173-177

  Donato, Giuseppe ^a   Conforti, Francesco ^a   Zuccalà, Valeria ^a   Russo, Emilio ^a   Maltese, Lorenza ^a   Perrotta, Ida ^b   Amorosi, Andrea ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY OF CALABRIA   (Italy)

Author keywords

Angiogenesis; Cardiac myxoma; CD44; Extracellular matrix; Tenascin c

Indexed keywords

CD44V ANTIGEN; CD44V6 ANTIGEN; HERMES ANTIGEN; KI 67 ANTIGEN; TENASCIN;

ADULT; ANGIOGENESIS; ARTICLE; CANCER CELL; CELL AGGREGATION; CELL DIFFERENTIATION; CELL MEMBRANE; CELL MOTILITY; CELL PROLIFERATION; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; EXTRACELLULAR MATRIX; FEMALE; HEART ATRIUM MYXOMA; HEART LEFT ATRIUM; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; MALE; MULTINUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TISSUE STRUCTURE;

ANTIGENS, CD44; FEMALE; HEART NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MYXOMA; NEOVASCULARIZATION, PATHOLOGIC; TENASCIN;

EID: 65049088408     PISSN: 10548807     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carpath.2008.03.006     Document Type: Article

References (30)

1. Burke A.P., Tazelaar H., Gomez-Roman J.J., et al. Benign tumours of pluripotent mesenchyme. In: Travis W.D., Brambilla E., Müller-Hermelink H.K., and Harris C.C. (Eds). Pathology and genetics of tumours of the lung, pleura, thymus and heart (2004), IARC Press, Lyon, France 260-265
2. In: Virmani R., Burke A., Farb A., and Atkinson J.B. (Eds). Cardiovascular pathology (2001), Saunders, Philadelphia 437-440
3. Negishi M., Sakamoto H., Sakamaki T., Ishikawa O., Kanda T., Tamura J., Kurabayashi M., and Nagai R. Disaccharide analysis of glycosaminoglycans synthesized by cardiac myxoma cells in tumor tissues and in cell culture. Life Sci 73 (2003) 1579-1582
4. Lam R.M., Hawkins E.T., and Roszka J. Cardiac myxoma histochemical and ultrastructural localization of glycosaminoglycans and proteoglycans. Ultrastructural Pathol 6 (1984) 69-81
5. Cao G., Savani R.C., Fehrenbach M., Lyons C., Zhang L., Coukos G., and DeLisser H.M. Involvement of endothelial CD44 during in vivo angiogenesis. Am J Pathol 169 (2006) 325-336
6. Tanaka K., Hiraiwa N., Hashimoto H., Yamazaki Y., and Kusakabe M. Tenascin-C regulates angiogenesis in tumor through the regulation of vascular endothelial growth factor expression. Int J Cancer 108 (2004) 31-40
7. Kodama H., Hirotani T., Suzuki Y., Ogawa S., and Yamazaki K. Cardiomyogenic differentiation in cardiac myxoma expressing lineage-specific transcription factors. Am J Pathol 161 (2002) 381-389
8. Castellà E.M., Ariza A., Pellicer I., Fernandez-Vasalo A., and Ojanguren I. Differential expression of CD44v6 in metastases of intestinal and diffuse types of gastric carcinoma. J Clin Pathol 51 (1998) 134-137
9. Hsia H.C., and Schwarzbauer J.E. Meet the tenascin: multifunctional and mysterious. J Biol Chem 280 (2005) 26641-26644
10. Jones F.S., and Jones P.L. The tenascin family of ECM glycoproteins: structure, function, and regulation during embryonic development and tissue remodeling. Develop Dyn 218 (2000) 235-259
11. Folkman J., and Moscona A. Role of cell shape in growth control. Nature 273 (1978) 345-349
12. Chen C.S., Mrksich M., Huang S., Whitesides G.M., and Ingber D.E. Geometric control of cell life and death. Science 276 (1997) 1425-1428
13. Ballard V.L.T., Sharma A., Duignan I., Holm J.M., Holm J.M., Chin A., Choi R., Hajjar K.A., Wong S., and Edelberg J.M. Vascular tenascin-C regulates cardiac endothelial phenotype and neovascularization. FASEB J 20 (2006) 717-719
14. Orlandi A., Ciucci A., Ferlosio A., Pellegrino A., Chiariello L., and Spagnoli L.G. Increased expression and activity of matrix metalloproteinases characterize embolic cardiac myxoma. Am J Pathol 166 (2005) 1619-1627
15. Goussia A.C., Ioachim E.E., Peschos D., Assimakopoulos D.A., Skevas A., and Agnantis N.J. Expression of extracellular matrix protein tenascin in laryngeal epithelial lesions: correlation with fibronectin, CD44, cathepsin D and proliferation indices. Virch Arch 436 (2000) 579-584
16. Naor D., Sionov R.V., and Ish-Shalom D. CD44: structure, function, and association with the malignant process. Adv Cancer Res 71 (1997) 241-319
17. Goodison S., Urquidi V., and Tarin D. CD44 cell adhesion molecules. J Clin Pathol 52 (1999) 189-196
18. Feinberg R.N., and Beebe D.C. Hyaluronate in vasculogenesis. Science 220 (1985) 1177-1179
19. Donato G., Bianchi L., Martino G., Picardi P., and Marotta M. Extracellurar matrix may play a role in the genesis of the hidiatidiform mole. IRCS Med Sci 13 (1985) 312
20. West D.C., Hampson I.N., Arnold F., and Kumar S. Angiogenesis induced by degradation product of hyaluronic acid. Science 228 (1985) 1324-1326
21. Savani R.C., Cao G., Pooler P.M., Zaman A., Zhou Z., and De Lisser H.M. Differential involvement of the hyaluronan (HA) receptors CD44 and receptor for HA-mediated motility in endothelial cell function and angiogenesis. J Biol Chem 276 (2001) 36770-36778
22. Zhou H., Mitsuhashi N., Klein A., Barsky L.W., Barsky L.W., Weinberg K., Barr M.L., Demetriou A., and Wu G.D. The role of the hyaluran receptor CD44 in mesenchymal stem cell migration in the extracellular matrix. Stem Cells 24 (2006) 928-935
23. Donato G., Lavano A., Volpentesta G., Chirchiglia D., Signorelli C.D., and Tucci L. Expression of tenascin in astrocytic tumours: too much ado about nothing?. J Neurol Neurosurg Psychiatry 63 3 (1997) 413
24. Sarkar S., Nuttall R.K., Liu S., Edwards D.R., and Yong V.W. Tenascin-C stimulates glioma cell invasion through matrix metalloproteinase-12. Cancer Res 66 (2006) 11771-11780
25. Juuti A., Nordling S., Louhimo J., Lundin J., and Haglund C. Tenascin C expression is upregulated in pancreatic cancer and correlates with differentiation. J Clin Pathol 57 (2004) 1151-1155
26. Jothy S. CD44 and its partners in metastasis. Clin Exp Metastasis 20 (2003) 195-201
27. Alaniz L., Cabrera P.V., Blanco G., Ernst G., Rimoldi G., Alvarez E., and Hajos S.E. Interaction of CD44 with different forms of hyaluronic acid. Its role in adhesion and migration of tumor cells. Cell Commun Adhes 9 (2002) 117-130
28. Burke A.P., Veinot J.P., Loire R., et al. Tumours of the heart: introduction. In: Travis W.D., Brambilla E., Müller-Hermelink H.K., and Harris C.C. (Eds). Pathology and genetics of tumours of the lung, pleura, thymus and heart (2004), IARC Press, Lyon, France 251-253
29. Liu J., and Jiang G. CD44 and hematologic malignancies. Cell Mol Immunol 3 (2006) 359-365
30. Reardon D.A., Zalutsky M.R., and Bigner D.D. Antitenascin-C monoclonal antibody radioimmunotherapy for malignant glioma patients. Expert Rev Anticancer Ther 7 (2007) 675-687